Cargando…

Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity

Human respiratory syncytial virus (RSV) is a cause of lower respiratory tract infection in infants, young children, and older adults. There is no licensed vaccine and prophylactic treatment options are limited. The RSV fusion (F) glycoprotein is a target of host immunity and thus a focus for vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Nita, Tian, Jing-Hui, Flores, Rhonda, Jacobson, Kelsey, Walker, Michelle, Portnoff, Alyse, Gueber-Xabier, Mimi, Massare, Michael J., Glenn, Greg, Ellingsworth, Larry, Smith, Gale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711572/ https://www.ncbi.nlm.nih.gov/pubmed/33066540 http://dx.doi.org/10.3390/vaccines8040607

Ejemplares similares

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
por: Guebre-Xabier, Mimi, et al.
Publicado: (2020)

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
por: Tian, Jing-Hui, et al.
Publicado: (2021)

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization
por: Raghunandan, Rama, et al.
Publicado: (2014)

Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA
por: Portnoff, Alyse D., et al.
Publicado: (2020)

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination
por: Alter, Galit, et al.
Publicado: (2021)

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
por: Gilman, Morgan S. A., et al.
Publicado: (2015)

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M(™) vaccination
por: Gorman, Matthew J, et al.
Publicado: (2021)

Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein
por: Xie, Qingqing, et al.
Publicado: (2019)

Immune Correlates of Protection from Filovirus Efficacy Studies in Non-Human Primates
por: Triplett, Cheryl A., et al.
Publicado: (2022)

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
por: Logue, James, et al.
Publicado: (2023)

Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
por: Gorman, Matthew J., et al.
Publicado: (2021)

Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein
por: Harshbarger, Wayne, et al.
Publicado: (2021)

Immunoinformatics-Aided Analysis of RSV Fusion and Attachment Glycoproteins to Design a Potent Multi-Epitope Vaccine
por: Dar, Hamza Arshad, et al.
Publicado: (2022)

Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
por: Bangaru, Sandhya, et al.
Publicado: (2020)

Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
por: Bangaru, Sandhya, et al.
Publicado: (2020)

LB19. Progress Toward a Vaccine for Maternal Immunization to Prevent Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) in Infants
por: Fries, Louis, et al.
Publicado: (2018)

Epitope-Specific Serological Assays for RSV: Conformation Matters
por: Phung, Emily, et al.
Publicado: (2019)

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
por: Caidi, Hayat, et al.
Publicado: (2012)

Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
por: Rey, Gertrud U., et al.
Publicado: (2013)

In silico comparative structural and compositional analysis of glycoproteins of RSV to study the nature of stability and transmissibility of RSV A
por: Mitra, Debanjan, et al.
Publicado: (2022)

Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
por: Smith, Gale, et al.
Publicado: (2012)

New Neutralizing Epitope Exposed on the Domain II of Tick-Borne Encephalitis Virus Envelope Glycoprotein E
por: Matveev, Andrey, et al.
Publicado: (2023)

Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
por: Howell, Katie A., et al.
Publicado: (2016)

Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV
por: Steff, Ann-Muriel, et al.
Publicado: (2017)

A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV
por: Wen, Xiaolin, et al.
Publicado: (2016)

RSV glycoprotein and genomic RNA dynamics reveal filament assembly prior to the plasma membrane
por: Vanover, Daryll, et al.
Publicado: (2017)

Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes
por: Xiao, Xiao, et al.
Publicado: (2019)

Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein
por: Chen, Zhifeng, et al.
Publicado: (2016)

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
por: Liu, Ye V., et al.
Publicado: (2011)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

An engineered genetic selection for ternary protein complexes inspired by a natural three-component hitchhiker mechanism
por: Lee, Hyeon-Cheol, et al.
Publicado: (2014)

Fine epitope mapping of glycoprotein Gn in Guertu virus
por: Zhang, Jingyuan, et al.
Publicado: (2019)

Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
por: Gandolfo, Claudia, et al.
Publicado: (2021)

Epitope-specific airway-resident CD4(+) T cell dynamics during experimental human RSV infection
por: Guvenel, Aleks, et al.
Publicado: (2019)

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
por: Tang, Aimin, et al.
Publicado: (2019)

Detection of RSV Antibodies in Human Plasma by Enzyme Immunoassays
por: Jadhao, Samadhan J., et al.
Publicado: (2016)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Development of Safe and Effective RSV Vaccine by Modified CD4 Epitope in G Protein Core Fragment (Gcf)
por: Cheon, In Su, et al.
Publicado: (2014)

An antidote approach to reduce risk and broaden utility of antibody-based therapeutics
por: Portnoff, Alyse D., et al.
Publicado: (2017)

Respiratory Syncytial Virus Induced Type I IFN Production by pDC Is Regulated by RSV-Infected Airway Epithelial Cells, RSV-Exposed Monocytes and Virus Specific Antibodies
por: Schijf, Marcel A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qff2bui0ernbcuk7b77jbaae9i